MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial
Condition(s):Renal Cell Carcinoma; Stage I Renal Cell Cancer AJCC v8; Stage II Renal Cell Cancer AJCC v8Last Updated:December 1, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Stage I Renal Cell Cancer AJCC v8; Stage II Renal Cell Cancer AJCC v8Last Updated:December 1, 2021Withdrawn
Condition(s):Prostate CancerLast Updated:July 25, 2023Recruiting
Condition(s):Locally Advanced CancerLast Updated:July 13, 2023Recruiting
Condition(s):Bone MetastasesLast Updated:March 29, 2018Completed
Condition(s):Adenocarcinoma of the ProstateLast Updated:February 13, 2024Active, not recruiting
Condition(s):Patient With Radiotherapy (Linac MRI); Mobile Cancerous LesionLast Updated:October 17, 2023Recruiting
Condition(s):CancerLast Updated:January 30, 2024Recruiting
Condition(s):Prostate CancerLast Updated:September 7, 2018Unknown status
Condition(s):CancerLast Updated:November 9, 2023Recruiting
Condition(s):Rectal CancerLast Updated:November 22, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.